Total Payments
$4,125
2024 Payments
$379.62
Companies
15
Transactions
75
Medicare Patients
3,022
Medicare Billing
$177,103
Payment Breakdown by Category
Food & Beverage$4,125 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,125 | 75 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,410 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $290.38 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $276.67 | 4 | $0 (2018) |
| Lilly USA, LLC | $233.85 | 2 | $0 (2023) |
| Dexcom, Inc. | $230.69 | 2 | $0 (2023) |
| Merge Healthcare Incorporated | $150.10 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $125.00 | 1 | $0 (2018) |
| Celgene Corporation | $117.34 | 1 | $0 (2019) |
| Edwards Lifesciences Corporation | $94.86 | 1 | $0 (2024) |
| Boston Scientific Corporation | $91.91 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $379.62 | 4 | ABBVIE INC. ($192.85) |
| 2023 | $247.85 | 3 | Dexcom, Inc. ($116.70) |
| 2022 | $1,158 | 19 | ABBVIE INC. ($705.68) |
| 2021 | $493.76 | 10 | AbbVie Inc. ($475.90) |
| 2020 | $98.85 | 3 | AbbVie Inc. ($98.85) |
| 2019 | $768.94 | 18 | AbbVie, Inc. ($590.46) |
| 2018 | $484.80 | 11 | AbbVie, Inc. ($239.83) |
| 2017 | $492.76 | 7 | Novartis Pharmaceuticals Corporation ($261.50) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $92.47 | General |
| 02/22/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $94.86 | General |
| 02/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $91.91 | General |
| Category: General - EP_EP | ||||||
| 01/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $100.38 | General |
| 05/17/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $21.71 | General |
| 04/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $109.44 | General |
| Category: Diabetes | ||||||
| 03/23/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $116.70 | General |
| Category: Endocrinology | ||||||
| 09/30/2022 | Merge Healthcare Incorporated | Software (Device) | Food and Beverage | Cash or cash equivalent | $107.14 | General |
| Category: Medical Imaging | ||||||
| 09/30/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $85.95 | General |
| 09/29/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $107.95 | General |
| 09/28/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $77.68 | General |
| 08/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Cardio-renal | ||||||
| 08/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.41 | General |
| Category: Diabetes | ||||||
| 08/04/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $113.99 | General |
| Category: Endocrinology | ||||||
| 07/27/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $74.96 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardio-renal | ||||||
| 05/31/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: DIABETES | ||||||
| 05/24/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Bone Health | ||||||
| 05/18/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.60 | General |
| 04/28/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $87.31 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2022 | Merge Healthcare Incorporated | Software (Device) | Food and Beverage | Cash or cash equivalent | $42.96 | General |
| Category: Medical Imaging | ||||||
| 03/11/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $121.81 | General |
| 03/09/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $28.03 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 717 | 1,067 | $183,082 | $40,559 |
| 2022 | 15 | 814 | 1,120 | $180,265 | $37,796 |
| 2021 | 9 | 712 | 998 | $161,857 | $50,149 |
| 2020 | 13 | 779 | 1,147 | $180,558 | $48,600 |
Total Patients
3,022
Total Services
4,332
Medicare Billing
$177,103
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 438 | $98,112 | $13,399 | 13.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 88 | 90 | $12,150 | $6,801 | 56.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $30,127 | $4,872 | 16.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $9,328 | $4,517 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 106 | $16,748 | $3,764 | 22.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 89 | 91 | $4,641 | $2,610 | 56.2% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 13 | 13 | $3,406 | $1,859 | 54.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 20 | 28 | $2,884 | $841.92 | 29.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 63 | $3,213 | $518.09 | 16.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $752.00 | $458.88 | 61.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 13 | 13 | $377.00 | $369.46 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 31 | $1,085 | $296.52 | 27.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 37 | $259.00 | $253.82 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 415 | $92,960 | $12,967 | 13.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 85 | 88 | $11,880 | $6,104 | 51.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 141 | $22,278 | $5,457 | 24.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 115 | 115 | $27,715 | $4,423 | 16.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 86 | 90 | $4,590 | $2,444 | 53.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $4,524 | $1,688 | 37.3% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 26 | 27 | $2,376 | $980.42 | 41.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 29 | 29 | $4,290 | $944.62 | 22.0% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 20 | 20 | $1,760 | $725.44 | 41.2% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 17 | 17 | $1,496 | $610.47 | 40.8% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 21 | 23 | $2,369 | $512.64 | 21.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 16 | 16 | $2,592 | $488.84 | 18.9% |
About Dr. Thomas Mihelich, MD
Dr. Thomas Mihelich, MD is a Internal Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538193214.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Mihelich, MD has received a total of $4,125 in payments from pharmaceutical and medical device companies, with $379.62 received in 2024. These payments were reported across 75 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,125).
As a Medicare-enrolled provider, Mihelich has provided services to 3,022 Medicare beneficiaries, totaling 4,332 services with total Medicare billing of $177,103. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tulsa, OK
- Active Since 07/10/2006
- Last Updated 03/09/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1538193214
Products in Payments
- Humira (Biological) $569.46
- ENTRESTO (Drug) $276.67
- HUMIRA (Biological) $267.66
- MOUNJARO (Drug) $233.85
- FARXIGA (Drug) $185.02
- Software (Device) $150.10
- STEGLATRO (Drug) $125.00
- Otezla (Drug) $117.34
- DEXCOM G7 GSS (161) (Medical Supply) $116.70
- Dexcom G6 Transmitter (Medical Supply) $113.99
- Mavyret (Drug) $68.08
- Kerendia (Drug) $35.55
- Orilissa (Drug) $32.18
- Viekira Pak (Drug) $28.07
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $22.00
- RELISTOR (Drug) $17.86
- JARDIANCE (Drug) $14.51
- EVENITY (Biological) $14.09
- BYDUREON (Drug) $11.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tulsa
Dr. Anuj Malik, Md, MD
Internal Medicine — Payments: $559,128
Internal Medicine $559,128
Mousumi Som, Do, DO
Internal Medicine — Payments: $182,416
Internal Medicine $182,416
Madhuri Lad, D.o, D.O
Internal Medicine — Payments: $160,090
Internal Medicine $160,090
Jesse Richards, D.o, D.O
Internal Medicine — Payments: $147,415
Internal Medicine $147,415
Dr. Stacy Chronister, D.o, D.O
Internal Medicine — Payments: $118,921
Internal Medicine $118,921
Mr. Eugene Ichinose, M.d, M.D
Internal Medicine — Payments: $113,876
Internal Medicine $113,876